Abstract

A novel expression system based on engineered variants of the yeast (Saccharomyces cerevisiae) dsRNA virus L-A was developed allowing the in vivo assembly of chimeric virus-like particles (VLPs) as a unique platform for a wide range of applications. We show that polypeptides fused to the viral capsid protein Gag self-assemble into isometric VLP chimeras carrying their cargo inside the capsid, thereby not only effectively preventing proteolytic degradation in the host cell cytosol, but also allowing the expression of a per se cytotoxic protein. Carboxyterminal extension of Gag by T cell epitopes from human cytomegalovirus pp65 resulted in the formation of hybrid VLPs that strongly activated antigen-specific CD8+ memory T cells ex vivo. Besides being a carrier for polypeptides inducing antigen-specific immune responses in vivo, VLP chimeras were also shown to be effective in the expression and purification of (i) a heterologous model protein (GFP), (ii) a per se toxic protein (K28 α-subunit), and (iii) a particle-associated and fully recyclable biotechnologically relevant enzyme (esterase A). Thus, yeast viral Gag represents a unique platform for the in vivo assembly of chimeric VLPs, equally attractive and useful in vaccine development and recombinant protein production.

Highlights

  • Viral expression systems can be classified into three types based on the regulatory and/or structural viral component that drives protein expression: (i) plasmid-based vectors containing promoter elements from either pro- or eukaryotic viruses; (ii) infectious viral vectors in which the gene of interest is integrated into the viral genome and expressed from a viral promoter in an appropriate host; (iii) virus-like particles (VLPs), called pseudovirions, representing subunit structures composed of multiple copies of a viral capsid and/or envelope protein capable to self-assemble into VLPs of defined spherical symmetry in vivo [1,2,3]

  • Chimeric Gag assembles into yeast VLPs

  • Electron micrograph of recombinant Gag/EstA particles prepared from yeast were purified by sucrose gradient centrifugation, negatively stained with uranyl acetate/methyl cellulose and subsequently used for electron microscopy. (B) Linear correlation between the 4nitrophenol concentration of up to 1 mM and its absorption at 405 nm. (C) Kinetics of Gag/EstA-driven hydrolysis of 4-nitrophenylacetate (280 mM) to 4-nitrophenol and acetate at 25uC in PBS50 buffer. (D) Coomassie-Blue staining and western analysis of Gag/EstA particles before and after cata-lysis and recycling by ultracentrifugation

Read more

Summary

Introduction

Viral expression systems can be classified into three types based on the regulatory and/or structural viral component that drives protein expression: (i) plasmid-based vectors containing promoter elements from either pro- or eukaryotic viruses; (ii) infectious viral vectors in which the gene of interest is integrated into the viral genome and expressed from a viral promoter in an appropriate host; (iii) virus-like particles (VLPs), called pseudovirions, representing subunit structures composed of multiple copies of a viral capsid and/or envelope protein capable to self-assemble into VLPs of defined spherical symmetry in vivo [1,2,3]. Most VLPs can be produced in large quantity in a heterologous host. Due to their particle structure and high molecular weight, VLPs can be purified in a preparative scale. A number of particle forming proteins tolerate insertion of foreign amino acid sequences without affecting in vivo self-assembly competence. Such chimeric or hybrid VLPs, exploited as platform for the display of antigenic determinants in a polyvalent manner, have already been shown to be promising candidates in the development of various subunit vaccines [5]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.